The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis.
about
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsStaphylococcal adaptation to diverse physiologic niches: an overview of transcriptomic and phenotypic changes in different biological environmentsMice lacking tartrate-resistant acid phosphatase (Acp 5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen, Staphylococcus aureusThe Staphylococcal Biofilm: Adhesins, Regulation, and Host ResponseIdentification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection.Capsule production and growth phase influence binding of complement to Staphylococcus aureusSeptic arthritis: immunopathogenesis, experimental models and therapyStaphylococcus aureus capsular polysaccharide types 5 and 8 reduce killing by bovine neutrophils in vitroThe zwitterionic cell wall teichoic acid of Staphylococcus aureus provokes skin abscesses in mice by a novel CD4+ T-cell-dependent mechanism.Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model.Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence.Staphylococcus aureus protein A binds to osteoblasts and triggers signals that weaken bone in osteomyelitis.Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides.Capsule expression by bovine isolates of Staphylococcus aureus from Argentina: genetic and epidemiologic analyses.Genetic and serologic evaluation of capsule production by bovine mammary isolates of Staphylococcus aureus and other Staphylococcus spp. from Europe and the United States.Promoter analysis of the cap8 operon, involved in type 8 capsular polysaccharide production in Staphylococcus aureus.Functional analysis of the Staphylococcus aureus collagen adhesin B domainDevelopment and characterization of a Staphylococcus aureus nasal colonization model in mice.The capsule is a virulence determinant in the pathogenesis of Pasteurella multocida M1404 (B:2).Staphylococcus aureus Cap5O has UDP-ManNAc dehydrogenase activity and is essential for capsule expression.Staphylococcus aureus AI-2 quorum sensing associates with the KdpDE two-component system to regulate capsular polysaccharide synthesis and virulence.Acute septic arthritis.Regulation of Staphylococcus aureus capsular polysaccharide expression by agr and sarA.Characterization of the structure and biological functions of a capsular polysaccharide produced by Staphylococcus saprophyticusOverproduction of type 8 capsular polysaccharide augments Staphylococcus aureus virulence.Staphylococcus aureus CcpA affects virulence determinant production and antibiotic resistance.Evaluation of capsular and acapsular strains of S. aureus in an experimental brain abscess modelAvailability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis.Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolatesCD4+ T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infectionsDifferential arthritogenicity of Staphylococcus aureus strains isolated from biological samples.The Sbi protein is a multifunctional immune evasion factor of Staphylococcus aureusStaphylococcus aureus capsular polysaccharides.sigmaB and the sigmaB-dependent arlRS and yabJ-spoVG loci affect capsule formation in Staphylococcus aureusExploring Staphylococcus aureus pathways to disease for vaccine development.The RpoB H₄₈₁Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus.MsaB activates capsule production at the transcription level in Staphylococcus aureus.Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity.MgrA activates expression of capsule genes, but not the α-toxin gene in experimental Staphylococcus aureus endocarditis.Interaction of staphylococci with bone.
P2860
Q24646677-E7D9C436-F37F-4D09-891B-BAF874F8E637Q28087340-63BFB8D8-A7E0-40F5-ACD5-489CC715EA7AQ28347466-F01604E7-E2B6-49FD-9593-43C9316EB49EQ28829672-825FD3E8-B907-4C02-A4B5-2CD25767B468Q33244198-FE547DF3-D64F-4739-B4C3-F407478E3D49Q33552644-F0BC15B7-0A9C-41CB-90CF-80493919C9A2Q33597430-4D46B030-0080-418B-A1E1-61A03FC78C79Q33716167-21137110-31D0-4DF4-BD43-C58ACCD33BB7Q33719517-7E52DC2B-AB85-407F-BF27-08B776BE782EQ33767412-A931B0F4-E37A-441C-A6FB-A899AC9A3A5CQ33788238-2ED9507D-E01B-4061-9800-C5DBE73A219FQ33883360-244819FC-A019-4AD1-AF06-940CE27D773DQ33931083-57F7143B-C1F9-4759-9D41-106BCA86FB41Q33965596-42598A26-868A-44A8-95FB-CD263E97DEFBQ33968870-1256C25F-B522-4984-88B9-C0B68A0AD7DFQ33991770-26A1A2C2-B423-442F-8D3A-9532E4075B40Q34001400-3351B9EF-FB23-479B-9CCE-9A7967CCFF9FQ34001970-0F2184EA-2DF0-4544-AA6D-481B00790882Q34004762-D762384A-9B6A-4C90-8370-B6E4D7D31B2EQ34005978-BB7CD745-D7ED-4BE4-B5CC-7D593A2BA6D4Q34045106-9398278C-46C4-47BF-9F7C-70E0D9AB1AE6Q34102880-0276EF4C-C69C-4049-B89B-72AE917E0FA1Q34116833-47E017A8-5C56-4493-832A-8319DADB3280Q34119229-ABCB0F37-2272-43F8-B4E4-B840F6C84D94Q34126226-3DE3F3EC-AA22-4361-8F8D-4152985CBDD1Q34510564-2EE7D4D4-B161-45C9-9437-7FEE1CBD84F0Q34575461-F9489E2D-EE3B-4FCF-96AA-8A8B46EEDEE9Q34581644-1BA89E6B-1BBF-41D0-ADD6-142CBE6E7A39Q34595644-0491C4E6-34D8-4B4F-ADB8-412CAB07E926Q34772232-DE52B951-AE6B-4248-9CD8-32F5BBBB1D6DQ34976399-EDB0872F-84E6-4235-A5F7-0B9EA1396C2BQ35191984-18932BAC-E161-4B97-98E8-22379A85A3C0Q35630504-A76A002F-EE45-4C21-B567-5E1B85B8E701Q35947273-8DB46A71-28E1-4F8F-8039-741D5C4F89D0Q36516970-760A5D14-FCC3-4C97-BC1A-07B7389AADA5Q36787486-F023D2BC-3F44-4854-89C4-391D05F334F5Q36966028-0F8F487B-B214-4CDF-9FED-0D47F011A9AAQ37229481-62E44B87-84F0-4E45-B3C0-39D0189CF01DQ37272332-2E8235B4-F9EB-4751-93C8-96B33BEE4333Q37627430-05BE3569-E508-4E48-A4D2-87130E9B0E2F
P2860
The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
The role of staphylococcal pol ...... pticemia and septic arthritis.
@en
The role of staphylococcal pol ...... pticemia and septic arthritis.
@nl
type
label
The role of staphylococcal pol ...... pticemia and septic arthritis.
@en
The role of staphylococcal pol ...... pticemia and septic arthritis.
@nl
prefLabel
The role of staphylococcal pol ...... pticemia and septic arthritis.
@en
The role of staphylococcal pol ...... pticemia and septic arthritis.
@nl
P2093
P2860
P1476
The role of staphylococcal pol ...... epticemia and septic arthritis
@en
P2093
P2860
P304
P407
P577
1997-10-01T00:00:00Z